Document is current
Any future updates will be listed below
-
Authors
Garcia Sanchez, Juan Jose https://orcid.org/0000-0001-6546-7769
Barraclough, Katherine A.
Cases, Aleix
Pecoits-Filho, Roberto
Germond-Duret, Celine
Zoccali, Carmine
Embleton, Nina
Wright, Antony
Hubbert, Luke
Nicholson, Lindsay
Barone, Salvatore
Budgen, Nigel
Cabrera, Claudia
Selvarajah, Viknesh
Eckelman, Matthew J.
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 14 August 2024
Accepted: 15 October 2024
First Online: 14 November 2024
Declarations
:
: Katherine A. Barraclough, Aleix Cases, Roberto Pecoits-Filho, Celine Germond-Duret, Carmine Zoccali, and Matthew J. Eckelman received consulting fees for taking part in Scientific Steering Committee meetings regarding CKD environmental impact research. Aleix Cases has received research grants from CSL Vifor; consultancy fees from Astellas, Astra Zeneca, Bayer, Boehringer Ingelheim, GSK, Lilly, Novo Nordisk, Otsuka, CSL Vifor, and lecture fees from Astellas, Astra Zeneca, Amgen, Bayer, Medscape, Novo Nordisk, Sanofi (Mexico), CSL Vifor. Roberto Pecoits-Filho has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Alexion, Akebia, AstraZeneca, Bayer, Boehringer, and Fresenius Medical Care. Juan Jose Garcia Sanchez, Salvatore Barone, Nigel Budgen, Claudia Cabrera, and Viknesh Selvarajah are employees and shareholders of AstraZeneca. Nina Embleton, Antony Wright, Luke Hubbert, and Lindsay Nicholson received consulting fees from AstraZeneca.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
